Subthalamic Nucleus Versus Globus Pallidus Internus Deep Brain Stimulation: Translating the Rematch Into Clinical Practice

Movement Disorders Clinical Practice

Volumn 1, Issue 1, 2014, Pages 24-35

  Williams, Nolan R ^a   Foote, Kelly D ^b   Okun, Michael S ^b  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Deep brain stimulation; Globus pallidus interna; Parkinson's disease; Subthalamic nucleus

Indexed keywords

ARTICLE; BEHAVIOR CHANGE; BRADYKINESIA; BRAIN DEPTH STIMULATION; CLINICAL PRACTICE; GAIT; GLOBUS PALLIDUS; HUMAN; NEUROPSYCHOLOGY; PRIORITY JOURNAL; PSYCHIATRY; QUALITY OF LIFE; SENSORIMOTOR CORTEX; SPEECH; SUBTHALAMIC NUCLEUS; SUICIDE; SWALLOWING;

EID: 85029600530     PISSN: None     EISSN: 23301619     Source Type: Journal    
DOI: 10.1002/mdc3.12004     Document Type: Article

References (114)

1. Williams NR, Okun MG. Deep brain stimulation (DBS) at the interface of neurology and psychiatry. J Clin Invest 2013;123:4546-4556.
2. Schuepbach WM, Rau J, Knudsen K, et al. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:610-622.
3. Taba HA, Wu SS, Foote KD, et al. A closer look at unilateral versus bilateral deep brain stimulation: results of the National Institutes of Health COMPARE cohort. J Neurosurg 2010;113:1224-1229.
4. Okun MS, Foote KD. Parkinson's disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev Neurother 2010;10:1847-1857.
5. Laitinen LV, Bergenheim AT, Hariz MI. Leksell's posteroventral pallidotomy in the treatment of Parkinson's disease. J Neurosurg 1992;76:53-61.
6. Ghika J, Villemure JG, Fankhauser H, Favre J, Assal G, Ghika-Schmid F. Efficiency and safety of bilateral contemporaneous pallidal stimulation (deep brain stimulation) in levodopa-responsive patients with Parkinson's disease with severe motor fluctuations: a 2-year follow-up review. J Neurosurg 1998;89:713-718.
7. Kumar R, Lozano AM, Montgomery E, Lang AE. Pallidotomy and deep brain stimulation of the pallidum and subthalamic nucleus in advanced Parkinson's disease. Mov Disord 1998;13(Suppl 1):73-82.
8. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507-520.
9. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of the subthalamic nucleus for the alleviation of 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-induced parkinsonism in the primate. Mov Disord 1991;6:288-292.
10. Aziz TZ, Peggs D, Agarwal E, Sambrook MA, Crossman AR. Subthalamic nucleotomy alleviates parkinsonism in the 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)-exposed primate. Br J Neurosurg 1992;6:575-582.
11. Deep-Brain Stimulation for Parkinson's Disease Study G. Deep-brain stimulation of the subthalamic nucleus or the pars interna of the globus pallidus in Parkinson's disease. N Engl J Med 2001;345:956-963.
12. Krack P, Pollak P, Limousin P, et al. Subthalamic nucleus or internal pallidal stimulation in young onset Parkinson's disease. Brain 1998;121(Pt 3):451-457.
13. Okun MS, Foote KD. Subthalamic nucleus vs globus pallidus interna deep brain stimulation, the rematch: will pallidal deep brain stimulation make a triumphant return? Arch Neurol 2005;62:533-536.
14. Weaver FM, Follett KA, Stern M, et al. Randomized trial of deep brain stimulation for Parkinson disease: thirty-six-month outcomes. Neurology 2012;79:55-65.
15. Anderson VC, Burchiel KJ, Hogarth P, Favre J, Hammerstad JP. Pallidal vs subthalamic nucleus deep brain stimulation in Parkinson disease. Arch Neurol 2005;62:554-560.
16. Okun MS, Green J, Saben R, Gross R, Foote KD, Vitek JL. Mood changes with deep brain stimulation of STN and GPi: results of a pilot study. J Neurol Neurosurg Psychiatry 2003;74:1584-1586.
17. Bronstein JM, Tagliati M, Alterman RL, et al. Deep brain stimulation for Parkinson disease: an expert consensus and review of key issues. Arch Neurol 2011;68:165.
18. Deuschl G, Schade-Brittinger C, Krack P, et al. A randomized trial of deep-brain stimulation for Parkinson's disease. N Engl J Med 2006;355:896-908.
19. Weaver FM, Follett K, Stern M, et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 2009;301:63-73.
20. Williams A, Gill S, Varma T, et al. Deep brain stimulation plus best medical therapy versus best medical therapy alone for advanced Parkinson's disease (PD SURG trial): a randomised, open-label trial. Lancet Neurol 2010;9:581-591.
21. Carmona-Torre F, Martinez-Urbistondo D, Del Pozo JL. Neurostimulation for Parkinson's disease with early motor complications. N Engl J Med 2013;368:2037.
22. Charles PD, Van Blercom N, Krack P, et al. Predictors of effective bilateral subthalamic nucleus stimulation for PD. Neurology 2002;59:932-934.
23. Vingerhoets FJ, Villemure JG, Temperli P, Pollo C, Pralong E, Ghika J. Subthalamic DBS replaces levodopa in Parkinson's disease: two-year follow-up. Neurology 2002;58:396-401.
24. Morishita T, Rahman M, Foote KD, et al. DBS candidates that fall short on a levodopa challenge test: alternative and important indications. Neurologist 2011;17:263-268.
25. Okun MS, Tagliati M, Pourfar M, et al. Management of referred deep brain stimulation failures: a retrospective analysis from 2 movement disorders centers. Arch Neurol 2005;62:1250-1255.
26. Skidmore FM, Rodriguez RL, Fernandez HH, Goodman WK, Foote KD, Okun MS. Lessons learned in deep brain stimulation for movement and neuropsychiatric disorders. CNS Spectr 2006;11:521-536.
27. Okun MS, Foote KD. A mnemonic for Parkinson disease patients considering DBS: a tool to improve perceived outcome of surgery. Neurologist 2004;10:290.
28. Okun MS, Fernandez HH, Wu SS, et al. Cognition and mood in Parkinson's disease in subthalamic nucleus versus globus pallidus interna deep brain stimulation: the COMPARE trial. Ann Neurol 2009;65:586-595.
29. Follett KA, Weaver FM, Stern M, et al. Pallidal versus subthalamic deep-brain stimulation for Parkinson's disease. N Engl J Med 2010;362:2077-2091.
30. Odekerken VJ, van Laar T, Staal MJ, et al. Subthalamic nucleus versus globus pallidus bilateral deep brain stimulation for advanced Parkinson's disease (NSTAPS study): a randomised controlled trial. Lancet Neurol 2013;12:37-44.
31. Benarroch EE. Subthalamic nucleus and its connections: anatomic substrate for the network effects of deep brain stimulation. Neurology 2008;70:1991-1995.
32. Richter EO, Hoque T, Halliday W, Lozano AM, Saint-Cyr JA. Determining the position and size of the subthalamic nucleus based on magnetic resonance imaging results in patients with advanced Parkinson disease. J Neurosurg 2004;100:541-546.
33. Bejjani BP, Dormont D, Pidoux B, et al. Bilateral subthalamic stimulation for Parkinson's disease by using three-dimensional stereotactic magnetic resonance imaging and electrophysiological guidance. J Neurosurg 2000;92:615-625.
34. Guridi J, Rodriguez-Oroz MC, Lozano AM, et al. Targeting the basal ganglia for deep brain stimulation in Parkinson's disease. Neurology 2000;55(12 Suppl 6):S21-S28.
35. Xie T, Bernard J, Warnke P. Post subthalamic area deep brain stimulation for tremors: a mini-review. Transl Neurodegener 2012;1:20.
36. Mallet L, Schupbach M, N'Diaye K, et al. Stimulation of subterritories of the subthalamic nucleus reveals its role in the integration of the emotional and motor aspects of behavior. Proc Natl Acad Sci USA 2007;104:10661-10666.
37. Nambu A. Globus pallidus internal segment. Prog Brain Res 2007;160:135-150.
38. Coenen VA, Honey CR, Hurwitz T, et al. Medial forebrain bundle stimulation as a pathophysiological mechanism for hypomania in subthalamic nucleus deep brain stimulation for Parkinson's disease. Neurosurgery 2009;64:1106-1114; discussion 1114-1105.
39. Blomstedt P, Hariz MI, Lees A, et al. Acute severe depression induced by intraoperative stimulation of the substantia nigra: a case report. Parkinsonism Relat Disord 2008;14:253-256.
40. Landau WM, Perlmutter JS. Transient acute depression induced by high-frequency deep-brain stimulation. N Engl J Med 1999;341:1004.
41. Stefurak T, Mikulis D, Mayberg H, et al. Deep brain stimulation for Parkinson's disease dissociates mood and motor circuits: a functional MRI case study. Mov Disord 2003;18:1508-1516.
42. Sturman MM, Vaillancourt DE, Metman LV, Bakay RA, Corcos DM. Effects of subthalamic nucleus stimulation and medication on resting and postural tremor in Parkinson's disease. Brain 2004;127(Pt 9):2131-2143.
43. Tagliati M. Turning tables: should GPi become the preferred DBS target for Parkinson disease? Neurology 2012;79:19-20.
44. Blomstedt P, Fytagoridis A, Astrom M, Linder J, Forsgren L, Hariz MI. Unilateral caudal zona incerta deep brain stimulation for Parkinsonian tremor. Parkinsonism Relat Disord 2012;18:1062-1066.
45. Chaturvedi A, Foutz TJ, McIntyre CC. Current steering to activate targeted neural pathways during deep brain stimulation of the subthalamic region. Brain Stimul 2012;5:369-377.
46. Vasques X, Cif L, Mennessier G, Coubes P. A target-specific electrode and lead design for internal globus pallidus deep brain stimulation. Stereotact Funct Neurosurg 2010;88:129-137.
47. Stover NP, Okun MS, Evatt ML, Raju DV, Bakay RA, Vitek JL. Stimulation of the subthalamic nucleus in a patient with Parkinson disease and essential tremor. Arch Neurol 2005;62:141-143.
48. Favilla CG, Ullman D, Wagle Shukla A, Foote KD, Jacobson CEt, Okun MS. Worsening essential tremor following deep brain stimulation: disease progression versus tolerance. Brain 2012;135(Pt 5):1455-1462.
49. Oyama G, Foote KD, Hwynn N, et al. Rescue leads: a salvage technique for selected patients with a suboptimal response to standard DBS therapy. Parkinsonism Relat Disord 2011;17:451-455.
50. Moro E, Lozano AM, Pollak P, et al. Long-term results of a multicenter study on subthalamic and pallidal stimulation in Parkinson's disease. Mov Disord 2010;25:578-586.
51. Krack P, Hariz MI. Deep brain stimulation in Parkinson's disease: reconciliation of evidence-based medicine with clinical practice. Lancet Neurol 2013;12:25-26.
52. Montgomery EB Jr. Subthalamic versus globus pallidus deep brain stimulation. Lancet Neurol 2013;12:329.
53. St George RJ, Nutt JG, Burchiel KJ, Horak FB. A meta-regression of the long-term effects of deep brain stimulation on balance and gait in PD. Neurology 2010;75:1292-1299.
54. Rocchi L, Carlson-Kuhta P, Chiari L, Burchiel KJ, Hogarth P, Horak FB. Effects of deep brain stimulation in the subthalamic nucleus or globus pallidus internus on step initiation in Parkinson disease: laboratory investigation. J Neurosurg 2012;117:1141-1149.
55. St George RJ, Carlson-Kuhta P, Burchiel KJ, Hogarth P, Frank N, Horak FB. The effects of subthalamic and pallidal deep brain stimulation on postural responses in patients with Parkinson disease. J Neurosurg 2012;116:1347-1356.
56. Wu YR, Levy R, Ashby P, Tasker RR, Dostrovsky JO. Does stimulation of the GPi control dyskinesia by activating inhibitory axons? Mov Disord 2001;16:208-216.
57. Sgambato-Faure V, Cenci MA. Glutamatergic mechanisms in the dyskinesias induced by pharmacological dopamine replacement and deep brain stimulation for the treatment of Parkinson's disease. Prog Neurobiol 2012;96:69-86.
58. Katayama Y, Oshima H, Kano T, Kobayashi K, Fukaya C, Yamamoto T. Direct effect of subthalamic nucleus stimulation on levodopa-induced peak-dose dyskinesia in patients with Parkinson's disease. Stereotact Funct Neurosurg 2006;84:176-179.
59. Oyama G, Foote KD, Jacobson CE IV, et al. GPi and STN deep brain stimulation can suppress dyskinesia in Parkinson's disease. Parkinsonism Relat Disord 2012;18:814-818.
60. Martinez-Ramirez D, Giugni J, Vedam-Mai V, Wagle Shukla A, Malaty IA, McFarland NR, Rodriguez RL, Foote KD, Okun MS. The "brittle response" to Parkinsonapos;s disease medications: characterization and response to deep brain stimulation. PLoS One 2014; In press.
61. Nirenberg MJ. Dopamine agonist withdrawal syndrome and non-motor symptoms after Parkinson's disease surgery. Brain 2010;133:e155; author reply e156.
62. Cools R, Stefanova E, Barker RA, Robbins TW, Owen AM. Dopaminergic modulation of high-level cognition in Parkinson's disease: the role of the prefrontal cortex revealed by PET. Brain 2002;125(Pt 3):584-594.
63. Okun MS, Gallo BV, Mandybur G, et al. Subthalamic deep brain stimulation with a constant-current device in Parkinson's disease: an open-label randomised controlled trial. Lancet Neurol 2012;11:140-149.
64. Witt K, Granert O, Daniels C, et al. Relation of lead trajectory and electrode position to neuropsychological outcomes of subthalamic neurostimulation in Parkinson's disease: results from a randomized trial. Brain 2013;136(Pt 7):2109-2119.
65. Thobois S, Ardouin C, Lhommee E, et al. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation. Brain 2010;133(Pt 4):1111-1127.
66. Lhommee E, Klinger H, Thobois S, et al. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours. Brain 2012;135(Pt 5):1463-1477.
67. Odekerken VJ, de Haan RJ, Schurrman PR, de Bie RM. Authors' reply. Subthalamic versus globus pallidus deep brain stimulation. Lancet Neurol 2013;12:329.
68. Tomaszewski KJ, Holloway RG. Deep brain stimulation in the treatment of Parkinson's disease: a cost-effectiveness analysis. Neurology 2001;57:663-671.
69. Eggington S, Valldeoriola F, Chaudhuri KR, Ashkan K, Annoni E, Deuschl G. The cost-effectiveness of deep brain stimulation in combination with best medical therapy, versus best medical therapy alone, in advanced Parkinson's disease. J Neurol 2013.
70. Volkmann J, Herzog J, Kopper F, Deuschl G. Introduction to the programming of deep brain stimulators. Mov Disord 2002;17(Suppl 3):S181-S187.
71. Minguez-Castellanos A, Escamilla-Sevilla F, Katati MJ, et al. Different patterns of medication change after subthalamic or pallidal stimulation for Parkinson's disease: target related effect or selection bias? J Neurol Neurosurg Psychiatry 2005;76:34-39.
72. Kumar R. Methods for programming and patient management with deep brain stimulation of the globus pallidus for the treatment of advanced Parkinson's disease and dystonia. Mov Disord 2002;17(Suppl 3):S198-S207.
73. Zahodne LB, Okun MS, Foote KD, et al. Greater improvement in quality of life following unilateral deep brain stimulation surgery in the globus pallidus as compared to the subthalamic nucleus. J Neurol 2009;256:1321-1329.
74. Weintraub D, Duda JE, Carlson K, et al. Suicide ideation and behaviours after STN and GPi DBS surgery for Parkinson's disease: results from a randomised, controlled trial. J Neurol Neurosurg Psychiatry 2013;84:1113-1118.
75. Temel Y, Boothman LJ, Blokland A, et al. Inhibition of 5-HT neuron activity and induction of depressive-like behavior by high-frequency stimulation of the subthalamic nucleus. Proc Natl Acad Sci USA 2007;104:17087-17092.
76. Moum SJ, Price CC, Limotai N, et al. Effects of STN and GPi deep brain stimulation on impulse control disorders and dopamine dysregulation syndrome. PLoS One 2012;7:e29768.
77. Kim YE, Kim H, Kim HJ, Lee JY, Yun JY, Kim JY, et al. Effects of bilateral subthalamic nucleus deep brain stimulation on impulse control and repetitive behavior disorders in Parkinson's disease: Results from 89 patients. Mov Disord 2012;27(Suppl 1):828.
78. Frank MJ, Samanta J, Moustafa AA, Sherman SJ. Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism. Science 2007;318:1309-1312.
79. Ballanger B, van Eimeren T, Moro E, et al. Stimulation of the subthalamic nucleus and impulsivity: release your horses. Ann Neurol 2009;66:817-824.
80. Rodriguez-Oroz MC, Lopez-Azcarate J, Garcia-Garcia D, et al. Involvement of the subthalamic nucleus in impulse control disorders associated with Parkinson's disease. Brain 2011;134(Pt 1):36-49.
81. Okun MS, Weintraub D. Should impulse control disorders and dopamine dysregulation syndrome be indications for deep brain stimulation and intestinal levodopa? Mov Disord 2013;28:1915-1919.
82. Skodda S. Effect of deep brain stimulation on speech performance in Parkinson's disease. Parkinsons Dis 2012;2012:850596.
83. D'Alatri L, Paludetti G, Contarino MF, Galla S, Marchese MR, Bentivoglio AR. Effects of bilateral subthalamic nucleus stimulation and medication on parkinsonian speech impairment. J Voice 2008;22:365-372.
84. Pinto S, Gentil M, Fraix V, Benabid AL, Pollak P. Bilateral subthalamic stimulation effects on oral force control in Parkinson's disease. J Neurol 2003;250:179-187.
85. Gentil M, Chauvin P, Pinto S, Pollak P, Benabid AL. Effect of bilateral stimulation of the subthalamic nucleus on parkinsonian voice. Brain Lang 2001;78:233-240.
86. Kleiner-Fisman G, Herzog J, Fisman DN, et al. Subthalamic nucleus deep brain stimulation: summary and meta-analysis of outcomes. Mov Disord 2006;21(Suppl 14):S290-S304.
87. Hartinger M, Tripoliti E, Hardcastle WJ, Limousin P. Effects of medication and subthalamic nucleus deep brain stimulation on tongue movements in speakers with Parkinson's disease using electropalatography: a pilot study. Clin Linguist Phon 2011;25:210-230.
88. Putzer M, Barry WJ, Moringlane JR. Effect of bilateral stimulation of the subthalamic nucleus on different speech subsystems in patients with Parkinson's disease. Clin Linguist Phon 2008;22:957-973.
89. Farrell A, Theodoros D, Ward E, Hall B, Silburn P. Effects of neurosurgical management of Parkinson's disease on speech characteristics and oromotor function. J Speech Lang Hear Res 2005;48:5-20.
90. Troche MS, Brandimore AE, Foote KD, Okun MS. Swallowing and deep brain stimulation in Parkinson's disease: a systematic review. Parkinsonism Relat Disord 2013;19:783-788.
91. Ciucci MR, Barkmeier-Kraemer JM, Sherman SJ. Subthalamic nucleus deep brain stimulation improves deglutition in Parkinson's disease. Mov Disord 2008;23:676-683.
92. Lengerer S, Kipping J, Rommel N, et al. Deep-brain-stimulation does not impair deglutition in Parkinson's disease. Parkinsonism Relat Disord 2012;18:847-853.
93. Sundstedt S, Olofsson K, van Doorn J, Linder J, Nordh E, Blomstedt P. Swallowing function in Parkinson's patients following Zona Incerta deep brain stimulation. Acta Neurol Scand 2012;126:350-356.
94. Kulneff L, Sundstedt S, Olofsson K, et al. Deep brain stimulation - effects on swallowing function in Parkinson's disease. Acta Neurol Scand 2013;127:329-336.
95. Silbergleit AK, LeWitt P, Junn F, et al. Comparison of dysphagia before and after deep brain stimulation in Parkinson's disease. Mov Disord 2012;27:1763-1768.
96. Voon V, Krack P, Lang AE, et al. A multicentre study on suicide outcomes following subthalamic stimulation for Parkinson's disease. Brain 2008;131(Pt 10):2720-2728.
97. Flament M, Loas G, Godefroy O, Krystkowiak P. Suicide without depression after withdrawal of a dopamine agonist in a patient with Parkinson's disease. J Neuropsychiatry Clin Neurosci 2011;23:E32.
98. Hariz M. Early surgery for Parkinson's disease? Maybe, but not just yet. Lancet Neurol 2013;12:938-939.
99. Tanner CM. A second honeymoon for Parkinson's disease? N Engl J Med 2013;368:675-676.
100. Okun MS. Deep brain stimulation for Parkinson disease: time to change practice. NEJM J Watch 2012;1.
101. Freund HJ, Kuhn J, Lenartz D, et al. Cognitive functions in a patient with Parkinson-dementia syndrome undergoing deep brain stimulation. Arch Neurol 2009;66:781-785.
102. Servello D, Sassi M, Brambilla A, et al. De novo and rescue DBS leads for refractory Tourette syndrome patients with severe comorbid OCD: a multiple case report. J Neurol 2009;256:1533-1539.
103. Moscovich M, Morishita T, Foote KD, Favilla CG, Chen ZP, Okun MS. Effect of lead trajectory on the response of essential head tremor to deep brain stimulation. Parkinsonism Relat Disord 2013;19:789-794.
104. Alterman RL, Miravite J, Weisz D, Shils JL, Bressman SB, Tagliati M. Sixty hertz pallidal deep brain stimulation for primary torsion dystonia. Neurology 2007;69:681-688.
105. Frankemolle AM, Wu J, Noecker AM, et al. Reversing cognitive-motor impairments in Parkinson's disease patients using a computational modelling approach to deep brain stimulation programming. Brain 2010;133(Pt 3):746-761.
106. Swan BD, Grill WM, Turner DA. Investigation of deep brain stimulation mechanisms during implantable pulse generator replacement surgery. Neuromodulation 2013. doi: 10.1111/ner.12123.
107. Sudhyadhom A, McGregor K, Okun MS, et al. Delineation of motor and somatosensory thalamic subregions utilizing probabilistic diffusion tractography and electrophysiology. J Magn Reson Imaging 2013;37:600-609.
108. Ostrem JL, Galifianakis NB, Markun LC, et al. Clinical outcomes of PD patients having bilateral STN DBS using high-field interventional MR-imaging for lead placement. Clin Neurol Neurosurg 2012;115:708-712.
109. Maling N, Hashemiyoon R, Foote KD, Okun MS, Sanchez JC. Increased thalamic gamma band activity correlates with symptom relief following deep brain stimulation in humans with Tourette's syndrome. PLoS One 2012;7:e44215.
110. Bronte-Stewart H, Barberini C, Koop MM, Hill BC, Henderson JM, Wingeier B. The STN beta-band profile in Parkinson's disease is stationary and shows prolonged attenuation after deep brain stimulation. Exp Neurol 2009;215:20-28.
111. Williams NR SE, Sahlem GL, Kerns SE et al. Deep brain stimulation to the reward circuitry exerts antidepressant effects on treatment-resistant depression in a patient with Parkinson's disease. Biol Psychiatry 2014 ahead of print (Supplement-Conference Abstract).
112. Stefani A, Lozano AM, Peppe A, et al. Bilateral deep brain stimulation of the pedunculopontine and subthalamic nuclei in severe Parkinson's disease. Brain 2007;130(Pt 6):1596-1607.
113. Moro E, Hamani C, Poon YY, et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 2010;133(Pt 1):215-224.
114. Ferraye MU, Debu B, Fraix V, et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 2010;133(Pt 1):205-214.